Vaccination and allergy: EAACI position paper, practical aspects.
| Autor: | Nilsson L; Allergy Center, University Hospital, Linköping, Sweden., Brockow K; Department of Dermatology and Allergy Biederstein, Technical University Munich, Munich, Germany., Alm J; Sachs' Children and Youth Hospital and Karolinska Institutet, Södersjukhuset, Stockholm, Sweden., Cardona V; Allergy Section, Department of Internal Medicine, Hospital Universitari Vall d'Hebron, Barcelona, Spain., Caubet JC; Division of Paediatrics, University of Geneva, Genève, Switzerland., Gomes E; CHP, Porto, Portugal., Jenmalm MC; Unit of Autoimmunity and Immune Regulation, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden., Lau S; Pediatric Pneumology and Immunology, Charité Universitätsmedizin, Berlin, Germany., Netterlid E; Department of Occupational and Environmental Dermatology, Lund University, Malmö, Sweden.; The Public Health Agency of Sweden, Stockholm, Sweden., Schwarze J; Child Life & Health and MRC-Centre for Inflammation Research, The University of Edinburgh, Edinburgh, UK., Sheikh A; Asthma UK Centre for Applied Research, Usher Institute of Population Health Sciences and Informatics, The University of Edinburgh, Edinburgh, UK., Storsaeter J; Norwegian Institute of Public Health, Oslo, Norway., Skevaki C; Institute of Laboratory Medicine and Pathobiochemistry, Molecular Diagnostics, Philipps University Marburg, University Hospital Giessen and Marburg GmbH, Marburg, Germany., Terreehorst I; Department of ENT, AMC, Amsterdam, the Netherlands., Zanoni G; Immunology Unit, University Hospital, Verona, Italy. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology [Pediatr Allergy Immunol] 2017 Nov; Vol. 28 (7), pp. 628-640. Date of Electronic Publication: 2017 Oct 10. |
| DOI: | 10.1111/pai.12762 |
| Abstrakt: | Immunization is highly effective in preventing infectious diseases and therefore an indispensable public health measure. Allergic patients deserve access to the same publicly recommended immunizations as non-allergic patients unless risks associated with vaccination outweigh the gains. Whereas the number of reported possible allergic reactions to vaccines is high, confirmed vaccine-triggered allergic reactions are rare. Anaphylaxis following vaccination is rare, affecting <1/100 000, but can occur in any patient. Some patient groups, notably those with a previous allergic reaction to a vaccine or its components, are at heightened risk of allergic reaction and require special precautions. Allergic reactions, however, may occur in patients without known risk factors and cannot be predicted by currently available tools. Unwarranted fear and uncertainty can result in incomplete vaccination coverage for children and adults with or without allergy. In addition to concerns about an allergic reaction to the vaccine itself, there is fear that routine childhood immunization may promote the development of allergic sensitization and disease. Thus, although there is no evidence that routine childhood immunization increases the risk of allergy development, such risks need to be discussed. (© 2017 The Authors. Pediatric Allergy and Immunology Published by John Wiley & Sons Ltd.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|